T1	Outcomes 243 251	efficacy
T2	Outcomes 256 262	safety
T3	Outcomes 319 336	survival analyses
T4	Outcomes 349 355	safety
T5	Outcomes 666 684	antitumor activity
T6	Outcomes 689 696	safety.
T7	Outcomes 783 791	survival
T8	Outcomes 1032 1041	median OS
T9	Outcomes 1156 1158	OS
T10	Outcomes 1250 1308	Grade 3 or 4 fatigue, neutropenia, and febrile neutropenia
